Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Long-Term Debt Repayments (2019 - 2025)

Rockwell Medical (RMTI) has disclosed Long-Term Debt Repayments for 12 consecutive years, with $198000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Long-Term Debt Repayments fell 1.49% year-over-year to $198000.0, compared with a TTM value of $667000.0 through Sep 2025, down 60.7%, and an annual FY2024 reading of $646000.0, down 67.7% over the prior year.
  • Long-Term Debt Repayments was $198000.0 for Q3 2025 at Rockwell Medical, up from $67000.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $1.3 million in Q4 2023 and bottomed at $2000.0 in Q2 2022.
  • Average Long-Term Debt Repayments over 5 years is $405666.7, with a median of $245000.0 recorded in 2023.
  • The sharpest move saw Long-Term Debt Repayments soared 149.4% in 2023, then crashed 83.95% in 2024.
  • Year by year, Long-Term Debt Repayments stood at $874000.0 in 2021, then tumbled by 42.56% to $502000.0 in 2022, then skyrocketed by 149.4% to $1.3 million in 2023, then plummeted by 83.95% to $201000.0 in 2024, then fell by 1.49% to $198000.0 in 2025.
  • Business Quant data shows Long-Term Debt Repayments for RMTI at $198000.0 in Q3 2025, $67000.0 in Q2 2025, and $201000.0 in Q1 2025.